Detalhe da pesquisa
1.
Alveolar epithelial cell growth hormone releasing hormone receptor in alveolar epithelial inflammation.
Exp Lung Res
; 49(1): 152-164, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37584484
2.
Agonists of growth hormone-releasing hormone (GHRH) inhibit human experimental cancers in vivo by down-regulating receptors for GHRH.
Proc Natl Acad Sci U S A
; 115(47): 12028-12033, 2018 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30373845
3.
Inhibition of experimental small-cell and non-small-cell lung cancers by novel antagonists of growth hormone-releasing hormone.
Int J Cancer
; 142(11): 2394-2404, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29435973
4.
A new approach to the treatment of acute myeloid leukaemia targeting the receptor for growth hormone-releasing hormone.
Br J Haematol
; 181(4): 476-485, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29663325
5.
Beneficial effects of growth hormone-releasing hormone agonists on rat INS-1 cells and on streptozotocin-induced NOD/SCID mice.
Proc Natl Acad Sci U S A
; 112(44): 13651-6, 2015 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26474831
6.
Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists.
Proc Natl Acad Sci U S A
; 111(2): 781-6, 2014 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24379381
7.
Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist.
Proc Natl Acad Sci U S A
; 110(7): 2617-22, 2013 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23359692
8.
Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia.
Proc Natl Acad Sci U S A
; 108(9): 3755-60, 2011 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21321192
9.
Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in mice.
Proc Natl Acad Sci U S A
; 107(51): 22272-7, 2010 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-21135231
10.
Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers.
Cancer
; 118(3): 670-80, 2012 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21751186
11.
Combining growth hormone-releasing hormone antagonist with luteinizing hormone-releasing hormone antagonist greatly augments benign prostatic hyperplasia shrinkage.
J Urol
; 187(4): 1498-504, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22341819
12.
Inhibitory effects of GHRH antagonists on human GH-secreting adenoma tissue.
Neuroendocrinology
; 96(1): 81-8, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22377963
13.
Powerful inhibition of in-vivo growth of experimental hepatic cancers by bombesin/gastrin-releasing peptide antagonist RC-3940-II.
Anticancer Drugs
; 23(9): 906-13, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22926257
14.
Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity.
Peptides
; 150: 170716, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34952135
15.
LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia.
Prostate
; 71(7): 736-47, 2011 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20945403
16.
The effect of GHRH antagonists on human glioblastomas and their mechanism of action.
Int J Cancer
; 127(10): 2313-22, 2010 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20162575
17.
Expression of hypothalamic neurohormones and their receptors in the human eye.
Oncotarget
; 8(40): 66796-66814, 2017 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28977997
18.
New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor.
Oncotarget
; 6(12): 9728-39, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25797248
19.
Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function.
Cell Cycle
; 13(17): 2790-7, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25486366
20.
Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone.
Oncotarget
; 4(3): 422-32, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23518876